Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
A

ABIOMED Inc
LSE:0H7S

Watchlist Manager
ABIOMED Inc
LSE:0H7S
Watchlist
Price: 381.02 USD 0.08%
Market Cap: $17.2B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

0H7S Price Targets Summary
ABIOMED Inc

There are no price targets for 0H7S.
0H7S Lowest Forecast
Wall Street Target
Not Available
0H7S Average Forecast
Wall Street Target
Not Available
0H7S Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ABIOMED Inc Competitors:
Price Targets
UMBF
UMB Financial Corp
36% Upside
UMBF
UMB Financial Corp
36% Upside

Revenue
Forecast

24% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
24% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 8 years the compound annual growth rate for ABIOMED Inc's revenue is 24%. The projected CAGR for the next 3 years is 14%.

What are analyst estimates?

Operating Income
Forecast

53% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
53% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 8 years the compound annual growth rate for ABIOMED Inc's operating income is 53%. The projected CAGR for the next 3 years is 17%.

What are analyst estimates?

Net Income
Forecast

44% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
44% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

For the last 8 years the compound annual growth rate for ABIOMED Inc's net income is 44%. The projected CAGR for the next 3 years is 32%.

What are analyst estimates?

See Also

Summary
0H7S intrinsic value, competitors valuation, and company profile.
DCF Valuation
0H7S stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0H7S stock valuation using valuation multiples.
Wall Street Estimates
0H7S price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0H7S stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0H7S's stock price target?
Not Available

0H7S doesn't have any price targets made by Wall Street professionals.

What is ABIOMED Inc's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for ABIOMED Inc's revenue is 24%. The projected CAGR for the next 3 years is 14%.

What is ABIOMED Inc's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for ABIOMED Inc's operating income is 53%. The projected CAGR for the next 3 years is 17%.

What is ABIOMED Inc's Net Income forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for ABIOMED Inc's net income is 44%. The projected CAGR for the next 3 years is 32%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 324,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett